Ed Hotard - Profile and Investment Details

Investor Profile

Ed Hotard is a Venture Capital based in Spring, Texas, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, OncoResponse, Remix Therapeutics, Koning Corporation, LifeMine Therapeutics, Cero Therapeutics, Encoded Therapeutics, BroadPeak Global, Locanabio, Faraday Pharmaceuticals, Baosteel Metal Co., Ltd., AgBiome, Metacrine, One BioMed, SOLUTIA INC, Dexter CorporationHangzhou Just Biotherapeutics (Just China), Biopalette, Karuna Therapeutics, Homology Medicines, Aquarion Water Company, Sana Biotechnology, Nebula Genomics, Nohla Therapeutics, Hua Medicine, Vividion Therapeutics, CFL Flooring, SIAD S.p.A., Iwatani Industrial Gases Corporation, SIAD Engineering (Hangzhou), ImmuneID, Praxair, Inc, PT Samator Indo Gas Tbk, Epirium Bio, Singleron Biotechnologies, Global Industries, Ultivue, Quinpario Acquisition Corporation, Verve Therapeutics, Geneception, Aspen Neuroscience, Bit Bio, Quinpario Partners Acquisition Corporation 2, Erasca, Codiak Biosciences, Semma Therapeutics, UNITY Biotechnology, AnchorDx, Encodia, Sesh, EGenesis, Transcenta, Omniome, Maze Therapeutics, Resilience, ROME Therapeutics, Walden Biosciences, Sonoma BioTherapeutics, Vir Biotechnology, BlackThorn Therapeutics, Glympse Bio, Scholar Rock, Dewpoint Therapeutics, Shona Energy Company, Inc., Volastra Therapeutics, Global Power Equipment Group, Agrivida, ImmusanT, EQRx, Vizgen, Magnolia NeuroSciences, HiberCell, Gossamer Bio, Insitro, LunaPBC, Autobahn Therapeutics, CStone Pharmaceuticals, Nutcracker Therapeutics, Harvest Partners, Mindstrong, Albany International Corp., Boundless Bio, LunaDNA, Brii Biosciences, Baomarc Automotive Solutions SpA, Beam Therapeutics, Shanghai Baosteel Packaging Co., Ltd., Voxel8, Cytrellis Biosystems, Qihan Biotech, . Over time, Ed Hotard has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ed Hotard is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Life Science, Biotechnology, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Ed Hotard, as their portfolio suggests a familiarity and interest in this area.

Understanding Ed Hotard’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.